about
Contribution of the Endothelin System to the Genesis and Maintenance of Atrial Fibrillation: Review of the Literature and Clinical ImplicationsBrugada syndrome in the paediatric population: a comprehensive approach to clinical manifestations, diagnosis, and management.Pericardial adhesions as a consequence of cryoballoon ablation detected during the hybrid AF ablation procedure.Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.First experience of monitoring with cardiac event recorder electrocardiography Omron system in childhood population for sporadic, potentially arrhythmia-related symptoms.The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern.The importance of class-I antiarrhythmic drug test in the evaluation of patients with syncope: unmasking Brugada syndrome.The usefulness of the consensus clinical diagnostic criteria in Brugada syndrome.Prevalence, clinical characteristics and management of atrial fibrillation in patients with Brugada syndrome.Simultaneous wide and narrow QRS complex tachycardia: what is the mechanism?Safe single-dose administration of propofol in patients with established Brugada syndrome: a retrospective database analysis.Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome.Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up.The clinical significance of pregnancy in Brugada syndrome.Exercise-related Brugada pattern and monomorphic ventricular tachycardia in a patient with Brugada syndrome: interplay between body temperature, haemodynamics and vagal activity.Brugada syndrome in the young: an assessment of risk factors predicting future events.A score model to predict risk of events in patients with Brugada Syndrome.Long-term prognosis of drug-induced Brugada syndrome.Cryoballoon ablation for paroxysmal atrial fibrillation in septuagenarians: a prospective study.A novel electrocardiographic index for the diagnosis of diastolic dysfunctionThe Brugada syndrome: facts and controversies.Two-Year Follow-up in Atrial Fibrillation Patients Referred for Catheter Ablation of the Atrioventricular NodeGenetic basis of ventricular arrhythmias.Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.A critical analysis of the scientific evidence behind international guidelines related to cardiac arrhythmias.Complications of atrial fibrillation ablation: when prevention is better than cure.Role of ASA in the primary and secondary prevention of cardiovascular events.Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries.Role of the burden of premature atrial contractions during the blanking period following second-generation cryoballoon ablation in predicting late recurrences of atrial arrhythmias.Second-generation cryoballoon ablation in the setting of left common pulmonary veins: Procedural findings and clinical outcome.Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification.High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.'The role of novel oral anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation'.Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum.The Use of Cryoballoon Ablation in Atrial Fibrillation: Simplifying Pulmonary Vein Isolation?Repeat procedures after second-generation cryoballoon ablation as an index procedure for persistent atrial fibrillation: one-year follow-up.Pulmonary vein reconnection following catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: results of a multicenter analysis.Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.A Clinical Score Model to Predict Lethal Events in Young Patients (≤19 Years) With the Brugada Syndrome.
P50
Q26800225-58C5AEF5-A286-4812-AE5A-03CD059DEA40Q30251414-0FFF50B3-0289-4D1E-9101-D2774DD12BF6Q30847452-537E1596-7E6B-49D0-9578-630391728E1FQ33154721-8F40DEFD-D625-4A08-B66E-8C4063AF34D3Q33160073-393F1662-77BE-4137-A2C0-5633C16DA7B9Q33160209-14DF483D-5B7D-497A-BFAB-FC356DC3B3EEQ33160545-26A38DA9-570E-4C49-8863-84283E0EF068Q33161541-0FB9C9CC-BBC9-4E0E-BD82-11C0F5FEA66AQ33162102-DCC3B908-322F-4690-9274-9F459838A48FQ33162788-0D615FD3-1FB7-4202-AD62-8A117E11200BQ33163163-F25B654D-B8A4-4795-B468-41A549ECF853Q33163709-C6D1F29C-587F-4321-B988-0C05BAC70CFBQ33164037-43800ECC-FF01-45FF-9751-0A0E3A1D141FQ33164214-BD5F1457-DFB9-4145-ADDA-F3FD867E640AQ33165859-B4C22D67-AB9D-499A-8296-819F1BE91154Q33167792-917A257E-C77C-4CDC-89CD-15AC0C84EB01Q33168502-EAE94E57-1038-427D-9F23-EBF84D6273FEQ33168592-C8D284A1-F286-4BD1-A7C5-DB0B43C2E58AQ34104154-F21DAADC-7672-4C53-A017-7425F2A8A8B4Q35041183-D50AD88A-9354-4F80-B90D-94D4F0337941Q36819513-F957A862-E4F5-4900-91F4-56FB15D6BACBQ37115119-CD8E54F4-E99B-4C28-9648-096A61DB63D0Q37185606-D1CB0277-6A44-40FC-BA35-D726844FA7C6Q37495932-62BA8BE4-4783-4428-AE66-C5FAF54FEC92Q37849466-AACC8A45-8541-4C18-997C-93227E9EB895Q37904501-3361266B-D3AF-4E55-B65E-CB84D265BCD3Q38006210-126CA8D7-6F40-45EB-854A-C03BDAE672C2Q38217126-FF67EC5F-AE5B-47CF-8BDC-898ADC693CC6Q38690119-F05CD3DD-FB0F-4C2B-860A-13B44B1699A7Q38720295-F8A4E9FA-6E5C-461F-AF97-D13919127B08Q38770256-1D8859D4-D99D-4CC8-9723-F290ED0F136CQ38834462-2DEA1255-E425-4327-8EA4-F79514E9C0C3Q38878653-28AC239D-A4BF-491B-9720-2A2A3468592FQ39021349-14748FCD-B8E6-43BD-97E5-A5586A2BF85FQ39297311-DBCC43EB-D333-4CDE-8CA6-5F058EABBABAQ39300609-B7792692-989D-4780-9606-FA52B624ECE7Q39453064-970B10B4-3B95-4684-87F4-6568C7561076Q39541616-9D765DC1-A4A3-490C-BE2A-F84635A2F293Q39985226-216E9D22-CBD6-4ED1-9AB0-912775569CFAQ40114478-EEFBA2E2-0A8F-4FD9-BDC4-B098AC0C3701
P50
name
Gian-Battista Chierchia
@en
Gian-Battista Chierchia
@nl
type
label
Gian-Battista Chierchia
@en
Gian-Battista Chierchia
@nl
prefLabel
Gian-Battista Chierchia
@en
Gian-Battista Chierchia
@nl